EUCTR2013-004039-60-FR进行中（未招募）不适用
A multicenter study to evaluate a risk-adapted strategy for treatment of extra cranial non seminomateous malignant germ cell tumour in children, adolescent and young adult - TGM 2013 - NS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •I1.Age = 18 years
- •I2.Extra cranial non seminomateous malignant germ cell tumour (NSMGCT) except pure immature teratoma
- •I3.Signed informed consent by patient if age = 18 or by parents or legal guardian and child if possible
- •I4.Affiliation with a social security scheme.
- •I5. Effective contraception during the whole treatment and during 6 months after treatment for pubescent children when relevant
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 94
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 94
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •E1. Prior treatment with chemoterapy for this tumour
- •E2. Contra indication to planned treatments (cf. smPC)
- •E3. not possible long-term follow-up
- •E4. pregnant or breasfeeding women.
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate a risk-adapted treatment of extra cranial malignant germ cell in children, adolescent and young adultextra cranial non seminomateous malignant germ cell tumour in child, adolescent and young adultMedDRA version: 21.0 Level: LLT Classification code 10049516 Term: Malignant tumor System Organ Class: 100000004864EUCTR2013-004039-60-BECENTRE LEON BERARD94
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 20.0 Level: LLT Classification code 10019279 Term: Heart failure System Organ Class: 100000004849EUCTR2014-001971-30-PTovartis Pharma services AG1,980
已完成
3 期
A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ69610019280Heart FailureNL-OMON42095ovartis Pharma B.V.75
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioEUCTR2014-001971-30-FIovartis Pharma services AG5,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-LTovartis Pharma Services AG5,000